Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MA05 - Improving Outcomes in Locoregional NSCLC II
- 13:30 - 15:00
- 9/24/2018
- Location: Room 105
- Type: Mini Oral Abstract Session
- Track: Treatment of Locoregional Disease - NSCLC
-
+
MA05.02 - PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated with Durvalumab vs. Placebo After CRT
13:35 - 13:40 | Presenter: Johan F. Vansteenkiste | Author(s): Jarushka Naidoo, Corinne Faivre-Finn, Mustafa Özgüroğlu, Augusto Villegas, Davey Daniel, Shuji Murakami, Rina Hui, Ki Hyeong Lee, Byoung Chul Cho, Kaoru Kubota, Lynne Poole, Catherine Wadsworth, Phillip A. Dennis, Scott J Antonia
- Abstract
Loading...
-
+
OA05 - Clinical Trials in IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Advanced NSCLC
-
+
OA05.06 - CheckMate 227: Patient-Reported Outcomes of First-Line Nivolumab + Ipilimumab in High Tumor Mutational Burden Advanced NSCLC
14:25 - 14:35 | Presenter: Julie R. Brahmer | Author(s): Michael Schenker, Ki Hyeong Lee, Mariano Provencio, Makoto Nishio, Krzysztof Lesniewski-Kmak, Randeep Sangha, Samreen Ahmed, Judith Raimbourg, Kynan Feeney, Romain Corre, Fabio Andre Franke, Eduardo Richardet, John R. Penrod, Yong Yuan, Faith Nathan, Prabhu Bhagavatheeswaran, Michael De Rosa, Fiona Taylor, Rachael Lawrance, Martin Reck
- Abstract
Loading...
-
+
PL02 - Presidential Symposium - Top 5 Abstracts
- 08:15 - 09:45
- 9/25/2018
- Location: Plenary Hall
- Type: Plenary Session
- Track: Advanced NSCLC
-
+
PL02.01 - Overall Survival with Durvalumab Versus Placebo After Chemoradiotherapy in Stage III NSCLC: Updated Results from PACIFIC
08:15 - 08:25 | Presenter: Scott J Antonia | Author(s): Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto A. Chiappori, Ki Hyeong Lee, Maike De Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young-Chul Kim, Chris S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle Elaine Gray, Luis Paz-Ares, Javier De Castro Carpeño, Corinne Faivre-Finn, Martin Reck, Johan F. Vansteenkiste, David R. Spigel, Catherine Wadsworth, Maria Taboada, Phillip A. Dennis, Mustafa Özgüroğlu
- Abstract
Loading... -
+
PL02.03 - Brigatinib vs Crizotinib in Patients With ALK Inhibitor-Naive Advanced ALK+ NSCLC: First Report of a Phase 3 Trial (ALTA-1L)
08:30 - 08:40 | Presenter: Ross Camidge | Author(s): Hye Ryun Kim, Myung-Ju Ahn, James Chih-Hsin Yang, Ji-Youn Han, Jong-Seok Lee, Maximilian Johannes Hochmair, Jacky Yu-Chung Li, Gee-Chen Chang, Ki Hyeong Lee, Cesare Gridelli, Angelo Delmonte, Maria Rosario Garcia Campelo, Dong-Wan Kim, Alessandra Bearz, Frank Griesinger, Alessandro Morabito, Enriqueta Felip, Raffaele Califano, Sharmistha Ghosh, Alexander Spira, Scott N. Gettinger, Marcello Tiseo, Jeff Haney, David Kerstein, Sanjay Popat
- Abstract
Loading...
-
+
P2.12 - Small Cell Lung Cancer/NET (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.12-01 - Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study
16:45 - 18:00 | Presenter: Jin-Hyoung Kang | Author(s): Ki Hyeong Lee, Dong-Wan Kim, Sang-We Kim, Hye Ryun Kim, Joo-Hang Kim, Jin Hyuk Choi, Ho Jung An, Jin-Soo Kim, Joung Soon Jang, Bong-Seog Kim, Heung Tae Kim
- Abstract
Loading...
-
+
MA26 - New Therapies and Emerging Data in ALK, EGFR and ROS1
- 13:30 - 15:00
- 9/26/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA26.10 - CNS Activity of Ramucirumab in Combination with Osimertinib in Patients with Advanced T790M-Positive EGFR-Mutant NSCLC
14:35 - 14:40 | Presenter: Luis Paz-Ares | Author(s): David Planchard, James Chih-Hsin Yang, Ki Hyeong Lee, Pilar Garrido, Keunchil Park, Joo-Hang Kim, Dae Ho Lee, Huzhang Mao, Bo H Chao, Helena Yu
- Abstract
Loading... -
+
MA26.11 - Effects of Dose Modifications on the Safety and Efficacy of Dacomitinib for EGFR Mutation-Positive NSCLC
14:40 - 14:45 | Presenter: Yi-Long Wu | Author(s): Tony S. Mok, Kazuhiko Nakagawa, Rafael Rosell, Ki Hyeong Lee, Jesus Corral, Maria Rita Migliorino, Adam Pluzanski, Rolf Linke, Geeta Devgan, Eric I. Sbar, Susan Quinn, Tao Wang
- Abstract
Loading...